Rheumatology Article | Spondyloarthritis

14 Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat gouty arthritis by suppressing inflammation: Results of a randomized, dose-ranging study Full Text Arthritis … 16 Evaluation of the safety of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis: Results from a randomized controlled trial Arthritis & Rheumatism, March 2, …

Originally posted here: 
Rheumatology Article | Spondyloarthritis

No comments yet.

TOP